(1)
Pharmacoeconomic Analysis of Cost Comparison Between Calcium Channel Blocker (CCB) and Angiotensin II Receptor Blocker (ARB) Antihypertensive Drugs in Hospitalized Hypertensive Patients at RSU Royal Prima. JFM 2026, 8 (2), 1146-1155. https://doi.org/10.35451/y2fhvc35.